Keros Therapeutics, Inc. · NASDAQ:KROS

ADAR1 Capital Management, LLC reported a 13.27% stake in Keros Therapeutics, Inc. (Schedule 13D/A)

Event May 12, 2025 · Filed May 12, 2025

ADAR1 Capital Management, LLC reported a 13.27% stake in Keros Therapeutics, Inc., 5,390,964 shares, with active intent on May 12, 2025. Filed May 12, 2025 (Schedule 13D/A).

Stake
13.27%
Shares
5,390,964
Intent
Active
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
ADAR1 Capital Management, LLC13.27%5,390,964
ADAR1 Capital Management GP, LLC11.44%4,647,406
Daniel Schneeberger13.27%5,390,964

Source

View original at SEC

Related